Inventor

KROEPLIEN BORIS

GB26 patents

⚠️ This page may combine multiple inventors who share the name “KROEPLIEN BORIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KROEPLIEN BORIS

UCB BIOPHARMA SPRL

Imidazopyridazine derivatives as modulators of TNF activity

Tetrahydroimidazopyridine derivatives as modulators of TNF activity

Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers

Fused tricyclic imidazole derivatives as modulators of TNF activity

Fused tricyclic benzimidazoles derivatives as modulators of TNF activity

Fused Tricyclic imidazole derivatives as modulators of TNF activity

Fused imidazole and pyrazole derivatives as modulators of TNF activity

Imidazopyridine derivatives as modulators of TNF activity

TNF -α modulating benzimidazoles

Fused bicyclic heteroaromatic derivatives as modulators of TNF activity

Imidazopyridine derivatives as modulators of TNF activity

Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity

Benzotriazole derivatives as modulators of TNF activity

Pyrazolopyridine derivatives as modulators of TNF activity

Imidazopyridine derivatives as modulators of TNF activity

Tetrahydrobenzimidazole derivatives as modulators of TNF activity

Fused imidazole and pyrazole derivatives as modulators of TNF activity

Purine derivatives as modulators of TNF activity

Tetrahydroimidazopyridine derivatives as modulators of TNF activity

Imidazopyrimidine derivatives as modulators of TNF activity

Tetrahydroimidazopyridine derivatives as modulators of TNF activity

UCB Biopharma SRL

TNF receptor signaling modulator assay

Methods of identifying signaling modulators of the trimeric TNFa

Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors

Method of identifying potential inhibitors of APO TNFα trimers

Complexes between CD40 and compounds comprising benzimidazole moieties